0001209191-23-041553.txt : 20230706
0001209191-23-041553.hdr.sgml : 20230706
20230706163526
ACCESSION NUMBER: 0001209191-23-041553
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230704
FILED AS OF DATE: 20230706
DATE AS OF CHANGE: 20230706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huang Jane
CENTRAL INDEX KEY: 0001683913
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39527
FILM NUMBER: 231074064
MAIL ADDRESS:
STREET 1: C/O MOURANT OZANNES CORPORATE SERVICES
STREET 2: 94 SOLARIS AVENUE
CITY: CAMANA BAY, GRAND CAYMAN
STATE: E9
ZIP: KY1-1108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prelude Therapeutics Inc
CENTRAL INDEX KEY: 0001678660
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811384762
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 POWDER MILL ROAD
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: (302) 547-3768
MAIL ADDRESS:
STREET 1: 200 POWDER MILL ROAD
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: Prelude Therapeutics Inc.
DATE OF NAME CHANGE: 20160630
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-07-04
0
0001678660
Prelude Therapeutics Inc
PRLD
0001683913
Huang Jane
C/O PRELUDE THERAPEUTICS INCORPORATED
200 POWDER MILL ROAD
WILMINGTON
DE
19801
0
1
0
0
President, CMO
0
Common Stock
2023-07-04
4
M
0
9375
A
33595
D
Common Stock
2023-07-04
4
F
0
3242
4.65
D
30353
D
Restricted Stock Unit
2023-07-04
4
M
0
9375
0.00
D
Common Stock
9375
103125
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock.
Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs.
The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date.
/s/ Laurent Chardonnet, Attorney-in-Fact
2023-07-06